PMID: 32890338DOI: 10.1097/ta.0000000000002938Sep 6, 2020Paper

Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.

The Journal of Trauma and Acute Care Surgery
Calvin H YehPaul Y Kim
Get PDF

Abstract

No abstract listed.

References

Efficacy and safety of recombinant human activated protein C for severe sepsis

Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

May 14, 2005·Critical Care Medicine·Pierre-Francois LaterreUNKNOWN PROWESS Clinical Evaluation Committee

Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial

Oct 25, 2006·Journal of Thrombosis and Haemostasis : JTH·H SaitoN Aoki

Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C

Sep 26, 2007·The Journal of Experimental Medicine·Edward J KerschenHartmut Weiler

Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes

Dec 21, 2010·Journal of Thrombosis and Haemostasis : JTH·L J ToltlP C Liaw

Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy

Dec 17, 2011·PloS One·Venizelos PapayannopoulosArturo Zychlinsky

Drotrecogin alfa (activated) in adults with septic shock

May 24, 2012·The New England Journal of Medicine·V Marco RanieriUNKNOWN PROWESS-SHOCK Study Group

Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test--ROTEM

Dec 3, 2014·Journal of Critical Care·Shivesh PrakashAndrew Bersten

Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study

Feb 24, 2015·Journal of Intensive Care·Takashi TagamiShigeki Kushimoto

Can rotational thromboelastometry predict septic disseminated intravascular coagulation?

Jul 22, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Hiroyuki KoamiSatoshi Inoue

DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC

Jan 19, 2016·Blood Reviews·Patricia LiawSacha Zeerleder

Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia

Apr 5, 2016·Cellular & Molecular Immunology·Yan Yang, Hong Tang

Acute Respiratory Distress Syndrome

Aug 10, 2017·The New England Journal of Medicine·B Taylor ThompsonKathleen D Liu

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis

Sep 15, 2017·Journal of Intensive Care·Toshiaki Iba, Jecko Thachil

Immunohaemostasis: a new view on haemostasis during sepsis

Dec 5, 2017·Annals of Intensive Care·Xavier DelabrancheFerhat Meziani

Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury

Sep 5, 2018·Frontiers in Immunology·Cong LiuHong-Long Ji

Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis

Dec 15, 2018·Journal of Critical Care·Yaqi OuyangRenyu Ding

Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis

Jan 1, 2019·Thrombosis and Haemostasis·Kazuma YamakawaMorio Aihara

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Jan 28, 2020·Lancet·Chaolin HuangBin Cao

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Feb 3, 2020·Lancet·Nanshan ChenLi Zhang

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Feb 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Ning TangZiyong Sun

Clinical Characteristics of Coronavirus Disease 2019 in China.

Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Mar 3, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sufang TianShu-Yuan Xiao

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Mar 15, 2020·Lancet·Fei ZhouBin Cao

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

Mar 17, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Huan HanCheng-Liang Zhu

Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

Apr 9, 2020·Journal of Thrombosis and Haemostasis : JTH·Janice WangChristopher D Barrett

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Apr 9, 2020·The New England Journal of Medicine·Yan ZhangShuyang Zhang

Pathogenesis of COVID-19 from a cell biologic perspective

Apr 10, 2020·The European Respiratory Journal·Robert J Mason

COVID-19: immunopathology and its implications for therapy.

Apr 11, 2020·Nature Reviews. Immunology·Xuetao Cao

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?

Apr 14, 2020·The Journal of Trauma and Acute Care Surgery·Hunter B MooreMichael B Yaffe

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Apr 16, 2020·Thrombosis Research·F A KlokH Endeman

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Apr 16, 2020·Intensive Care Medicine·Luciano GattinoniLuigi Camporota

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Apr 16, 2020·Journal of Thrombosis and Haemostasis : JTH·Marisa DolhnikoffElnara Marcia Negri

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Apr 18, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Cynthia MagroJeffrey Laurence

Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

Apr 18, 2020·Journal of Thrombosis and Haemostasis : JTH·Mauro PanigadaArmando Tripodi

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.

Apr 18, 2020·Journal of Thrombosis and Haemostasis : JTH·Marco RanucciLorenzo Menicanti

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Apr 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Litao ZhangZhenlu Zhang

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Apr 21, 2020·Journal of the American College of Cardiology·Behnood BikdeliUNKNOWN Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working

ISTH interim guidance on recognition and management of coagulopathy in COVID-19.

Apr 28, 2020·Journal of Thrombosis and Haemostasis : JTH·Jecko ThachilToshiaki Iba

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

May 6, 2020·Intensive Care Medicine·Julie HelmsUNKNOWN CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sep

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.

May 7, 2020·Annals of Internal Medicine·Dominic WichmannStefan Kluge

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

May 11, 2020·Journal of the American College of Cardiology·Ishan ParanjpeGirish N Nadkarni

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.

May 28, 2020·Journal of Thrombosis and Haemostasis : JTH·Alex C SpyropoulosUNKNOWN Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the Int

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.

May 31, 2020·The Lancet. Respiratory Medicine·Sharon E FoxRichard S Vander Heide

❮ Previous
Next ❯

Citations

Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19.

Feb 26, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Annabelle DupontUNKNOWN Lille Covid Research Network (LICORNE)

COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations.

Jul 22, 2021·International Journal of Laboratory Hematology·Jerrold H LevyJean M Connors

Is pulse oximeter a reliable tool for non-critically ill patients with COVID-19?

Oct 13, 2021·International Journal of Clinical Practice·Aslıhan Gürün KayaAkın Kaya

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04357730

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved